Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shanhong Guan

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Journal of Biopharmaceutical Statistics|October 19, 2012
Statistical designs for early phases of cancer clinical trialsShanhong Guan
Optics Express|July 19, 2020
Low spurious optoelectronic oscillator achieved by frequency conversion filtering without deteriorating phase noiseShanhong Guan, Qizhuang Cen, Feifei Yin, et al.
Light, Science & Applications|June 23, 2020
Optoelectronic parametric oscillatorTengfei Hao, Qizhuang Cen, Shanhong Guan, et al.
Optics Letters|November 1, 2023
Phase-diagram investigation of frustrated 1D and 2D Ising models in OEO-based Ising machineQizhuang Cen, Hao Ding, Shanhong Guan, et al.
Light, Science & Applications|November 26, 2022
Large-scale coherent Ising machine based on optoelectronic parametric oscillatorQizhuang Cen, Hao Ding, Tengfei Hao, et al.
American Journal of Hematology|October 18, 2019
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphomaAlex F Herrera, Andre Goy, Amitkumar Mehta, et al.
Haematologica|April 10, 2025
Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 studyTae Min Kim, Nehal J Lakhani, Jacob Soumerai, et al.
Oncology|June 24, 2019
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid TumorsDavid Hong, Drew Rasco, Michael Veeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2021
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic MelanomaAdi Diab, Scott S Tykodi, Gregory A Daniels, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Journal of Biopharmaceutical Statistics|October 19, 2012
Statistical designs for early phases of cancer clinical trialsShanhong Guan
Optics Express|July 19, 2020
Low spurious optoelectronic oscillator achieved by frequency conversion filtering without deteriorating phase noiseShanhong Guan, Qizhuang Cen, Feifei Yin, et al.
Light, Science & Applications|June 23, 2020
Optoelectronic parametric oscillatorTengfei Hao, Qizhuang Cen, Shanhong Guan, et al.
Optics Letters|November 1, 2023
Phase-diagram investigation of frustrated 1D and 2D Ising models in OEO-based Ising machineQizhuang Cen, Hao Ding, Shanhong Guan, et al.
Light, Science & Applications|November 26, 2022
Large-scale coherent Ising machine based on optoelectronic parametric oscillatorQizhuang Cen, Hao Ding, Tengfei Hao, et al.
American Journal of Hematology|October 18, 2019
Safety and activity of ibrutinib in combination with durvalumab in patients with relapsed or refractory follicular lymphoma or diffuse large B-cell lymphomaAlex F Herrera, Andre Goy, Amitkumar Mehta, et al.
Haematologica|April 10, 2025
Evorpacept plus rituximab for the treatment of relapsed or refractory non-Hodgkin lymphoma: results from the phase I ASPEN-01 studyTae Min Kim, Nehal J Lakhani, Jacob Soumerai, et al.
Oncology|June 24, 2019
A Phase 1b/2 Study of the Bruton Tyrosine Kinase Inhibitor Ibrutinib and the PD-L1 Inhibitor Durvalumab in Patients with Pretreated Solid TumorsDavid Hong, Drew Rasco, Michael Veeder, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2021
Bempegaldesleukin Plus Nivolumab in First-Line Metastatic MelanomaAdi Diab, Scott S Tykodi, Gregory A Daniels, et al.
Pageof 1